Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored treatment of hepatitis C genotype 1
2007-001122-27Phase 4Completed
- Sponsor
- Region Västra Götaland
- Start
- Mar 2007
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of interferon alfa and ribavirin in hepatitis C virus infection, sponsored by Region Västra Götaland. Primary endpoint: Required treatment weeks per cured and non-cured patient. Started Mar 2007; status: completed.
02
Drugs
interferon alfaribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2007-001122-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001122-27.